Azenta (AZTA)
(Delayed Data from NSDQ)
$53.67 USD
+0.85 (1.61%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $53.71 +0.04 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
AZTA 53.67 +0.85(1.61%)
Will AZTA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AZTA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AZTA
10x Genomics (TXG) Surges 8.2%: Is This an Indication of Further Gains?
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
AZTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
Hims & Hers Health, Inc. (HIMS) Moves 8.3% Higher: Will This Strength Last?
Other News for AZTA
What's Driving ICU Medical Inc's Surprising 15% Stock Rally?
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
Azenta to Participate in the Jefferies Global Healthcare Conference
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Robotics Stocks
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK